
Tissue culture plant producer with rare cultivar portfolio seeks strategic equity partner to fuel growth
Licensed tissue culture plant producer with large-scale cloning operation, rare genetics portfolio, a growing export business & state-of-the-art lab facilities seeking $1.5 million "smart money" investment from strategic partner
Listing ID:
9958786864
Licence(s) Held:
Standard Cultivation and CRA license

Listing Details:
State of the art, purpose built, ~26,000 ft.² tissue culture and cultivation facility sitting on 1 acre of land
5,000 ft.² of GMP compliant tissue culture production lab and plantlet production space
Facility is comprised of mother and R&D grow rooms, 6 hardening rooms, tissue culture laboratory, 2x plantlet production rooms, picking and planting line room, separate receiving and quarantine, irrigation room, media preparation room, wash area, secure storage, office rooms, large shipping and packaging room, large clean and sterile room with shipping dock
Currently undertaking mother plant and seed production, phenotyping, tissue culture, cloning, propagation, storage and B2B international exports
Clone capacity - 2.2 million ready to flower plants, 4.7 Million 4”clones and 1.1 Million TC Clones
Company has built an expansive legal genetics catalogue, holding diverse seed and plant stock
Assembled a world class science team with plant-based genetics and cannabis experience
Has one of the largest R&D programs in Canada through its partnerships with multiple institutions
Has a range of breeder and cultivar royalty-type agreements in place
Licence holder also has an exclusive, leading-edge technology for modern tissue culture that improves efficiencies, maximizes production, and reduces operational costs
EU GMP facility in Europe is operational and LP is selling products to various clients and recently made additional shipments to Israel, the UK, and Greece
~10k ft.² of flowering space available to be worked into a deal with a strategic partner: Dried Flower capacity of 4000kg of custom craft flower available for B2B sales
The company has the ability, through strategic partnerships, to offer customized flower genetics, GACP, and flower conversion services in its EUGMP facility in Europe. Additionally, it can distribute its products directly to pharmacies in Germany via a wholesale distributor
Great opportunity to access unique, industry-leading genetics, as well as tissue culture and cloning services to support leading edge cannabis cultivation
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
45958479515
Profitable, GACP-Certified 3,500 ft² micro cultivator in Montreal, QC for $599k obo

Exceptional opportunity to acquire an operational, GACP-certified, 3,500 ft² licensed micro-cultivation located in a multi-unit industrial complex located in Montreal, QC, featuring significant profit potential
37240564521
Profitable, high-growth telemedicine platform serving the German medical cannabis market

Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
43087719945
Turnkey, GPP-Compliant micro-processing facility with rec sales in Toronto for $500k OBO

Unique opportunity to acquire a fully turnkey, leased, GPP-compliant licensed processing facility centrally 30 mins north of Toronto. Features a recreational sales license for both flower and extracts with significant on-site expansion potential

